0001104659-23-035178.txt : 20230321 0001104659-23-035178.hdr.sgml : 20230321 20230321175138 ACCESSION NUMBER: 0001104659-23-035178 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230320 FILED AS OF DATE: 20230321 DATE AS OF CHANGE: 20230321 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ek John Frederick CENTRAL INDEX KEY: 0001767921 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40344 FILM NUMBER: 23750687 MAIL ADDRESS: STREET 1: 5964 LA PLACE COURT CITY: CARLSBAD STATE: CA ZIP: 92008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Akoya Biosciences, Inc. CENTRAL INDEX KEY: 0001711933 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 475586242 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CAMPUS DRIVE STREET 2: 6TH FLOOR CITY: MARLBOROUGH STATE: MA ZIP: 01762 BUSINESS PHONE: 855.896.8401 MAIL ADDRESS: STREET 1: 100 CAMPUS DRIVE STREET 2: 6TH FLOOR CITY: MARLBOROUGH STATE: MA ZIP: 01762 4 1 tm239789-3_4seq1.xml OWNERSHIP DOCUMENT X0407 4 2023-03-20 0 0001711933 Akoya Biosciences, Inc. AKYA 0001767921 Ek John Frederick 100 CAMPUS DRIVE, 6TH FLOOR MARLBOROUGH MA 01762 0 1 0 0 CFO 0 Common Stock 2023-03-20 4 A 0 160000 0.00 A 160000 D Employee Stock Option (Right to Buy) 7.60 2023-03-20 4 A 0 160000 0.00 A 2033-03-20 Common Stock 160000 160000 D The restricted stock units shall vest in four (4) equal annual installments beginning on April 1, 2024, and annually thereafter until fully vested. Each restricted stock unit represents a contingent right to receive one share of Akoya Biosciences, Inc. common stock. The options shall vest as follows: twenty-five percent (25%) shall vest on March 20, 2024 with the remainder vesting in 36 equal monthly installments beginning on April 20, 2024. /s/ John Frederick Ek, by Brian McKelligon, as Attorney-in-Fact 2023-03-21